OSAKA -- Japanese drugmaker Shionogi & Co. said Friday that it has entered talks with the U.S. government to supply its oral medication for COVID-19 currently in development.
Shionogi is preparing for clinical trials for the drug in the U.S., due to begin this month at the earliest. The pill would be Japan's first domestically developed oral COVID treatment.
